EPS (Diluted) for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current diluted EPS (TTM) is $7.49. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$7.49
YoY change
+1.6%
5Y CAGR
+8.3%
Peak year (2021)
$8.67
Latest annual
$6.80
EPS (Diluted) history chart for West Pharmaceutical Services (WST) from 1985 to 2025
EPS (Diluted) history table for West Pharmaceutical Services (WST) from 1985 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $6.80 | +1.6% | ||
| 2024 | $6.69 | -15.1% | ||
| 2023 | $7.88 | +1.9% | ||
| 2022 | $7.73 | -10.8% | ||
| 2021 | $8.67 | +89.7% | ||
| 2020 | $4.57 | +42.4% | ||
| 2019 | $3.21 | +17.2% | ||
| 2018 | $2.74 | +37.7% | ||
| 2017 | $1.99 | +4.2% | ||
| 2016 | $1.91 | +46.9% | ||
| 2015 | $1.30 | -25.7% | ||
| 2014 | $1.75 | +11.5% | ||
| 2013 | $1.57 | +36.5% | ||
| 2012 | $1.15 | +6.5% | ||
| 2011 | $1.08 | +13.7% | ||
| 2010 | $0.95 | -10.4% | ||
| 2009 | $1.06 | -15.2% | ||
| 2008 | $1.25 | +22.5% | ||
| 2007 | $1.02 | +2.0% | ||
| 2006 | $1.00 | +40.8% | ||
| 2005 | $0.71 | +26.8% | ||
| 2004 | $0.56 | -25.3% | ||
| 2003 | $0.75 | +127.3% | ||
| 2002 | $0.33 | -464.2% | ||
| 2001 | $-0.09 | -462.4% | ||
| 2000 | $0.03 | -96.1% | ||
| 1999 | $0.64 | +540.0% | ||
| 1998 | $0.10 | -85.1% | ||
| 1997 | $0.67 | +168.0% | ||
| 1996 | $0.25 | -41.9% | ||
| 1995 | $0.43 | 0.0% | ||
| 1994 | $0.43 | +16.2% | ||
| 1993 | $0.37 | +19.4% | ||
| 1992 | $0.31 | -321.4% | ||
| 1991 | $-0.14 | -307.4% | ||
| 1990 | $0.07 | -78.9% | ||
| 1989 | $0.32 | +18.5% | ||
| 1988 | $0.27 | +28.6% | ||
| 1987 | $0.21 | -22.2% | ||
| 1986 | $0.27 | +12.5% | ||
| 1985 | $0.24 | — |
EPS (Diluted) values are taken from West Pharmaceutical Services's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, West Pharmaceutical Services (WST) diluted EPS totalled $6.80 – edged up 1.6% year-over-year.
Looking at the 2020–2025 (5 years) stretch, West Pharmaceutical Services diluted EPS compounded at +8.3% per year, with the latest reading among the more recent periods of the dataset.
West Pharmaceutical Services diluted EPS declined from $8.67 in 2021 to $6.80 in 2025, a 21.6% drawdown.
The highest annual diluted EPS of $8.67 was reported in 2021. The lowest in the available history was $-0.14 in 1991.
Among 8 Healthcare peers, West Pharmaceutical Services (WST) ranks 8th; the peer median for diluted EPS is $13.16.
West Pharmaceutical Services EPS (Diluted) by Year
West Pharmaceutical Services EPS (Diluted) 2025: $6.80
West Pharmaceutical Services diluted EPS in 2025 was $6.80, edged up 1.6% from 2024.
West Pharmaceutical Services EPS (Diluted) 2024: $6.69
West Pharmaceutical Services diluted EPS in 2024 was $6.69, declined 15.1% below 2023.
West Pharmaceutical Services EPS (Diluted) 2023: $7.88
West Pharmaceutical Services diluted EPS in 2023 was $7.88, edged up 1.9% from 2022.
West Pharmaceutical Services EPS (Diluted) 2022: $7.73
West Pharmaceutical Services diluted EPS in 2022 was $7.73, declined 10.8% below 2021.
West Pharmaceutical Services EPS (Diluted) 2021: $8.67
West Pharmaceutical Services diluted EPS in 2021 was $8.67.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — EPS (Diluted)
Companies in the same sector as West Pharmaceutical Services, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's diluted EPS?
- Latest reported diluted EPS for West Pharmaceutical Services (WST) is $7.49 (period ending March 31, 2026).
How has West Pharmaceutical Services diluted EPS changed year-over-year?
- West Pharmaceutical Services (WST) diluted EPS changed +1.6% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services diluted EPS?
- West Pharmaceutical Services (WST) diluted EPS compound annual growth rate is +8.3% over the most recent 5 years available.
When did West Pharmaceutical Services diluted EPS hit its highest annual value?
- West Pharmaceutical Services diluted EPS reached its highest annual value of $8.67 in 2021.
What was West Pharmaceutical Services diluted EPS in 2024?
- West Pharmaceutical Services (WST) diluted EPS in 2024 was $6.69.
What was West Pharmaceutical Services diluted EPS in 2025?
- West Pharmaceutical Services (WST) diluted EPS in 2025 was $6.80.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.